Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer

被引:17
|
作者
Bao, Zhirong [1 ]
Wang, Dajiang [1 ]
Chen, Shupeng [2 ]
Chen, Min [1 ]
Jiang, Dazhen [1 ]
Yang, Chunxu [1 ]
Liu, Hui [1 ]
Dai, Jing [1 ]
Xie, Conghua [1 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Hubei Key Lab Tumor Biol Behav,Hubei Canc Clin St, Wuhan, Hubei, Peoples R China
[2] William Beaumont Hosp, Dept Radiat Oncol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA
来源
RADIATION ONCOLOGY | 2019年 / 14卷 / 01期
关键词
Bone marrow sparing; Dose limitation; Cervical cancer; Intensity-modulated radiotherapy; ACUTE HEMATOLOGIC TOXICITY; SQUAMOUS-CELL CARCINOMA; RADIATION-THERAPY; CONCURRENT CISPLATIN; PELVIC RADIATION; DOSIMETRIC PARAMETERS; CHEMOTHERAPY; PROBABILITY; IMRT; CHEMORADIATION;
D O I
10.1186/s13014-019-1324-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background To quantify the dosimetric parameters of different bone marrow sparing strategies and to determine the optimal strategy for cervical cancer patients undergoing postoperative intensity-modulated radiotherapy (IMRT). Methods Fifteen patients with cervical cancer were selected for analysis. The planning target volume (PTV) and the organs at risks (OAR) including small bowel, bladder, rectum, femoral heads, os coxae (OC), lumbosacral spine (LS) and bone marrow (BM) were contoured. For each patient, four IMRT plans with different strategies were generated, including one plan without BM as the dose-volume constraint, namely IMRT (N) plan, and three bone marrow sparing (BMS-IMRT) plans. The three BMS-IMRT plans used the BM, OC, OC and LS respectively, as the BM OAR, namely as IMRT (BM), IMRT (OC) and IMRT (OC + LS) plans. Dose volumes for the target and the OARs were compared using analysis of variance (ANOVA). Results Compared with IMRT (N) plans, the dose to the small bowel, bladder, rectum and femoral heads showed no increase in the three BMS-IMRT plans. However, the irradiated dose to BM, OC and LS significantly decreased. In particular, the mean dose of BM, OC and LS decreased by about 5Gy (p < 0.05) in IMRT (BM) plans while the average volume receiving >= 20, >= 30, >= 40Gy decreased by 7.1-24.2%. The LS volume receiving 40Gy showed the highest decrease (about 31.2%, p < 0.05) in IMRT (OC + LS) plans. On the other hand, in comparison with IMRT (BM), IMRT (OC) reduced the dose volume of to the OC, but increased the dose to LS while IMRT (OC + LS) plans reduced both the OC and the LS volume at all dose levels. Specifically, the V-20 of OC and LS in the IMRT (OC + LS) plan decreased by 11.5 and 11.2%, respectively. Conclusion By introducing the os coxae and lumbosacral spine as the dose-volume constraints, the IMRT plans exhibited the best sparing of the bone marrow without compromising the dose to surrounding normal structures. Therefore, we recommend adding the os coxae and lumbosacral spine as the BM OAR in such plans.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Swallowing sparing intensity modulated radiotherapy versus standard parotid sparing intensity-modulated radiotherapy for treatment of head and neck cancer: a randomized clinical trial
    Ashour, May Gamal
    Shouman, Tarek Hamed
    Hassouna, Ashraf Hamed
    Mokhtar, Maha Hassan
    El Din, Reem Emad
    Youssef, Ayda Aly
    Gomaa, Mohammed Mohammed
    Abdelgeleel, Shaimaa
    ACTA ONCOLOGICA, 2022, 61 (02) : 134 - 140
  • [22] Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma
    D'Souza, WD
    Ahamad, AA
    Iyer, RB
    Salehpour, MR
    Jhingran, A
    Eifel, PJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (04): : 1062 - 1070
  • [23] BONE MARROW-SPARING INTENSITY-MODULATED RADIATION THERAPY FOR STAGE I SEMINOMA
    Zilli, T.
    Boudreau, C.
    Doucet, R.
    Alizadeh, M.
    Lambert, C.
    Nguyen, T. V.
    Taussky, D.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S399 - S399
  • [24] Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer
    Kavanagh, BD
    Schefter, TE
    Wu, QW
    Tong, SD
    Newman, F
    Arnfield, M
    Benedict, SH
    McCourt, S
    Mohan, R
    SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (03) : 260 - 271
  • [25] Bone marrow-sparing intensity-modulated radiation therapy for Stage I seminoma
    Zilli, Thomas
    Boudreau, Chantal
    Doucet, Robert
    Alizadeh, Moein
    Lambert, Carole
    Nguyen, Thu van
    Taussky, Daniel
    ACTA ONCOLOGICA, 2011, 50 (04) : 555 - 562
  • [26] Acceleration of dose calculations for intensity-modulated radiotherapy
    Siebers, JV
    Tong, SD
    Lauterbach, M
    Wu, QW
    Mohan, R
    MEDICAL PHYSICS, 2001, 28 (06) : 903 - 910
  • [27] Postoperative Hypofractionated Intensity-Modulated Radiotherapy With Concurrent Chemotherapy in Cervical Cancer
    Cho, Won Kyung
    Park, Won
    Kim, Sang-Won
    Lee, Kang Kyu
    Ahn, Ki Jung
    Choi, Jin Hwa
    JAMA ONCOLOGY, 2024, 10 (06) : 737 - 743
  • [28] Dosimetric comparison of helical tomotherapy and intensity-modulated radiotherapy in cervical cancer
    Liu, J.
    Zhu, L.
    Li, S.
    Gao, S.
    Yan, J.
    Xie, L.
    Hou, Z.
    Zhou, X.
    Liu, B.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S1005 - S1006
  • [29] Intensity-modulated radiotherapy for prostate cancer
    Fischer-Valuck, Ben W.
    Rao, Yuan James
    Michalski, Jeff M.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (03) : 297 - 307
  • [30] The effect of dose-painted intensity-modulated radiotherapy combined with chemotherapy for stage IIIB cervical cancer
    Liu, Yunqin
    Zang, Chunbao
    Qian, Liting
    Wu, Ailin
    Ke, Xue
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (04): : 2813 - 2821